MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ijid.2025.107803

Медицинская библиотека · International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2025

Antimicrobial susceptibility of clinical isolates of Stenotrophomonas maltophilia from Europe, Asia, and Latin America (2018-2023).

Sader Helio S, Mendes Rodrigo E, Doyle Timothy B, Winkler Marisa L, Castanheira Mariana

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

The occurrence of Stenotrophomonas maltophilia infections, especially pneumonia, has increased consistently in the last years. We evaluated the antimicrobial susceptibility of a large collection of S. maltophilia collected in Europe, Asia, and Latin America.

METHODS

Total 1287 clinical isolates were collected from 71 medical centres located in Western Europe (W-EU; n = 682; 28 centres in 10 countries), Eastern Europe and Mediterranean region (E-EU; n = 320; 18 centres in 11 countries), the Asia-Pacific region (APAC; n = 182; 15 centres in 7 countries), and Latin America (LATAM; n = 103; 10 centres in 7 countries). Most isolates were from patients with pneumonia (n = 790) and bloodstream infection (n = 234). Isolates were susceptibility tested by the CLSI broth microdilution method.

RESULTS

Aztreonam-avibactam was the most active compound against isolates from all regions and infection types (MIC50/90, 4/4 mg/l; 99.5% inhibited at ≤8 mg/l). The percentage of isolates inhibited at ≤8 mg/l varied from 99.3% in W-EU to 100.0% in APAC and LATAM. Trimethoprim-sulfamethoxazole (MIC50/90, ≤0.12/0.5 mg/l; 95.6/96.3% susceptible per CLSI/EUCAST) and minocycline (MIC50/90, 0.5/1 mg/l; 92.7% susceptible per CLSI) also were active. Aztreonam-avibactam remained active against trimethoprim-sulfamethoxazole-resistant isolates, inhibiting 100.0% at ≤8 mg/l.

CONCLUSIONS

Aztreonam-avibactam may represent a valuable option to treat S. maltophilia infections, addressing a major unmet medical need.

Для цитирования: Sader Helio S, Mendes Rodrigo E, Doyle Timothy B, Winkler Marisa L, Castanheira Mariana. Antimicrobial susceptibility of clinical isolates of Stenotrophomonas maltophilia from Europe, Asia, and Latin America (2018-2023).. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2025. DOI: 10.1016/j.ijid.2025.107803.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.